首页> 外国专利> A compound derived from Mandelic acid, its Pharmaceutical Composition and preparation procedure, useful for the inhibition of thrombin.To treat Thrombosis and Blood Hypercoagulable and / or tissues.

A compound derived from Mandelic acid, its Pharmaceutical Composition and preparation procedure, useful for the inhibition of thrombin.To treat Thrombosis and Blood Hypercoagulable and / or tissues.

机译:一种由扁桃酸衍生的化合物,其药物组成和制备方法,可用于抑制凝血酶。用于治疗血栓形成和血液高凝和/或组织。

摘要

A compound of formula I and their Derivatives (including pharmaceutically acceptable prodrugs), which are useful as such or as prodrugs,As competitive inhibitors of Trypsin like proteases, such as thrombin, and in particular, in the treatment of conditions where inhibition of Thrombin is required (e.g.Example Thrombosis) or as anticoagulants.
机译:本身或作为前药有用的式I化合物及其衍生物(包括药学上可接受的前药),可作为胰蛋白酶的竞争性抑制剂,例如蛋白酶,例如凝血酶,特别是用于治疗抑制凝血酶的疾病必需(例如血栓形成实例)或用作抗凝剂。

著录项

  • 公开/公告号CL2002001952A1

    专利类型

  • 公开/公告日2003-08-22

    原文格式PDF

  • 申请/专利权人 ASTRAZENECA AB;

    申请/专利号CL2002001952

  • 申请日2002-08-29

  • 分类号A61K31/397;A61K31/401;A61K31/4427;A61K31/506;A61P7/02;C07C47/575;C07C59/52;C07C59/64;C07C69/734;C07D205/04;C07D207/10;C07D401/12;C07D403/12;

  • 国家 CL

  • 入库时间 2022-08-22 00:03:39

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号